Home › NDC Lookup › RxCUI directory › RxCUI 866021

Cyproheptadine hydrochloride 0.4 MG/ML Oral Solution — RxCUI 866021

RxNorm drug concept · Semantic clinical drug
RxCUI 866021 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI866021
Official nameCyproheptadine hydrochloride 0.4 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascyproheptadine HCl 4 MG per 10 ML Oral Syrup; cyproheptadine HCl 2 MG in 5 mL Oral Solution; cyproheptadine HCl 2 MG per 5 ML Oral Solution
FDA products mapped9
Package NDCs mapped11
Reported Medicaid activity (SDUD)308,687 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cyproheptadine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cyproheptadine is an antihistamine used mainly for allergies. It can help with nasal allergy symptoms like a runny nose and sneezing, itchy or watery eyes, and skin reactions like...
  • What is cyproheptadine actually used for?
  • Yes — drowsiness is the most common side effect and is expected, especially when you first start taking it. For many people it eases up after a few days. That said, you should avoi...
  • Is it normal to feel really tired after taking this?
📖 Read our full Cyproheptadine guide →

🕸️ Concept Web — How Cyproheptadine hydrochloride 0.4 MG/ML Oral Solu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cyproheptadine hydrochloride 0.4 MG/ML Oral Solution RxCUI 866021

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Cyproheptadine 3013
    • Cyproheptadine hydrochloride 104592
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cyproheptadine Oral Solution 702213
    • Cyproheptadine hydrochloride Oral Solution 2648497
    • Cyproheptadine Oral Liquid Product 1151459
    • Cyproheptadine Oral Product 1151460
    • Cyproheptadine hydrochloride Oral Liquid Product 2659823
    • Cyproheptadine hydrochloride Oral Product 2663410
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cyproheptadine hydrochloride 0.4 MG/ML 866020

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cyproheptadine hydrochloride 0.4 MG/ML SCDC · 866020
  • Cyproheptadine Oral Solution SCDF · 702213
  • Cyproheptadine hydrochloride Oral Solution SCDFP · 2648497
  • Cyproheptadine Oral Liquid Product SCDG · 1151459
  • Cyproheptadine Oral Product SCDG · 1151460
  • Cyproheptadine hydrochloride Oral Liquid Product SCDGP · 2659823
  • Cyproheptadine hydrochloride Oral Product SCDGP · 2663410

📦 FDA Products & Package NDCs

9 products · 11 package NDCs
11 package NDCs map to RxCUI 866021 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
17856-0504-01 120 SYRINGE in 1 CASE (17856-0504-1) / 2.5 mL in 1 SYRINGE Cyproheptadine Hydrochloride Atlantic Biological Corp. 2026-04-30
27808-0099-01 473 mL in 1 BOTTLE, PLASTIC (27808-099-01) Cyproheptadine Hydrochloride Tris Pharma Inc 2022-12-30
39328-0544-16 473 mL in 1 BOTTLE, GLASS (39328-544-16) Cyproheptadine Hydrochloride Patrin Pharma, Inc. 2022-02-15
58657-0697-16 473 mL in 1 BOTTLE, GLASS (58657-697-16) cyproheptadine hydrochloride solution Method Pharmaceuticals, LLC 2024-06-15
62135-0949-47 473 mL in 1 BOTTLE (62135-949-47) CYPROHEPTADINE Chartwell RX, LLC 2022-07-13
62135-0949-94 946 mL in 1 BOTTLE (62135-949-94) CYPROHEPTADINE Chartwell RX, LLC 2022-07-13
64980-0504-48 473 mL in 1 BOTTLE (64980-504-48) Cyproheptadine Hydrochloride Rising Pharma Holdings, Inc. 2006-07-10
70752-0101-12 473 mL in 1 BOTTLE, GLASS (70752-101-12) CYPROHEPTADINE HYDROCHLORIDE QUAGEN PHARMACEUTICALS LLC 2019-05-22
70752-0185-12 473 mL in 1 BOTTLE, PLASTIC (70752-185-12) CYPROHEPTADINE HYDROCHLORIDE QUAGEN PHARMACEUTICALS LLC 2023-12-22
72162-2065-02 473 mL in 1 BOTTLE, GLASS (72162-2065-2) CYPROHEPTADINE HYDROCHLORIDE Bryant Ranch Prepack 2024-08-12
72162-2065-04 473 mL in 1 BOTTLE, GLASS (72162-2065-4) CYPROHEPTADINE HYDROCHLORIDE Bryant Ranch Prepack 2025-05-02
Observed labelers: Bryant Ranch Prepack (2) · Chartwell RX, LLC (2) · QUAGEN PHARMACEUTICALS LLC (2) · Atlantic Biological Corp. (1) · Method Pharmaceuticals, LLC (1) · Patrin Pharma, Inc. (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.